16426 Federal Register / Vol. 80, No. 59 / Friday, March 27, 2015 / Notices 

1The record is defined in sec. 207.2(f) of the 

Commission’s Rules of Practice and Procedure (19 

CFR 207.2(f)). 

2All six Commissioners voted in the affirmative. 

cannot guarantee that we will be able to 

do so. 

Authority: 40 CFR 1506.6, 40 CFR 1506.10, 

43 CFR 1610.2, 43 CFR 1610.5. 

Ruth Welch, 

BLM Colorado State Director. 

[FR Doc. 2015–07013 Filed 3–26–15; 8:45 am] 

BILLING CODE 4130–JB–P 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation Nos. 704–TA–1 and 734–TA– 

1 (Review)] 

Sugar from Mexico; Determinations 

On the basis of the record 1 developed 

in the subject reviews, the United States 

International Trade Commission 

(‘‘Commission’’) determines, pursuant 

to sections 704(h) and 734(h) of the 

Tariff Act of 1930 (19 U.S.C. 1671c(h) 

and 1673c(h)) (‘‘the Act’’), that 

agreements the U.S. Department of 

Commerce (‘‘Commerce’’) has entered 

into with Mexican exporters of sugar 

and the government of Mexico 

suspending antidumping and 

countervailing duty investigations 

concerning sugar from Mexico eliminate 

completely the injurious effect of 

subject imports.2

Background 

The Commission instituted these 

investigations effective January 8, 2015, 

following receipt of a petition filed with 

the Commission by Imperial Sugar 

Company (‘‘Imperial’’), Sugar Land, 

Texas and AmCane Sugar LLC 

(‘‘AmCane’’), Taylor, Michigan. The 

Commission determined that Imperial 

and AmCane are interested parties who 

were parties to the underlying 

investigations at the time the petitions 

were filed, and consequently are 

appropriate petitioning parties. Notice 

of the scheduling of these reviews and 

of a public oral presentation to be held 

in connection therewith was given by 

posting copies of the notice in the Office 

of the Secretary, U.S. International 

Trade Commission, Washington, DC, 

and by publishing the notice in the 

Federal Register on January 26, 2015 

(80 FR 3977). The oral presentation was 

held in Washington, DC, on February 

19, 2015, and all persons who requested 

the opportunity were permitted to 

appear in person or by counsel. 

The Commission completed and filed 

its determination in these reviews on 

March 24, 2015. The views of the 

Commission are contained in USITC 

Publication 4523 (April 2015), entitled 

Sugar From Mexico: Investigation Nos. 

704–TA–1 and 734–TA–1 (Review). 

By order of the Commission. 

Issued: March 24, 2015. 

Lisa R. Barton, 

Secretary to the Commission. 

[FR Doc. 2015–07071 Filed 3–26–15; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Importer of Controlled Substances 

Application: HOSPIRA 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic class, and applicants 

therefore, may file written comments on 

or objections to the issuance of the 

proposed registration in accordance 

with 21 CFR 1301.34(a) on or before 

April 27, 2015. Such persons may also 

file a written request for a hearing on 

the application pursuant to 21 CFR 

1301.43 on or before April 27, 2015. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/ODW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. Request for hearings should be 

sent to: Drug Enforcement 

Administration, Attention: Hearing 

Clerk/LJ, 8701 Morrissette Drive, 

Springfield, Virginia 22152 

SUPPLEMENTARY INFORMATION: The 

Attorney General has delegated his 

authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, dispensers, 

importers, and exporters of controlled 

substances (other than final orders in 

connection with suspension, denial, or 

revocation of registration) has been 

redelegated to the Deputy Assistant 

Administrator of the DEA Office of 

Diversion Control (‘‘Deputy Assistant 

Administrator’’) pursuant to section 7 of 

28 CFR pt. 0, subpt. R, App. 

In accordance with 21 CFR 

1301.34(a), this is notice that on October 

31, 2014, Hospira, 1776 North 

Centennial Drive, McPherson, Kansas 

67460–1247, applied to be registered as 

an importer of remifentanil (9739), a 

basic class of controlled substance listed 

in schedule II. 

The company plans to import 

remifentanil for use in dosage form 

manufacturing. 

Dated: March 20, 2015. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator. 

[FR Doc. 2015–06969 Filed 3–26–15; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Importer of Controlled Substances 

Application: Meda Pharmaceuticals, 

Inc. 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic class, and applicants 

therefore, may file written comments on 

or objections to the issuance of the 

proposed registration in accordance 

with 21 CFR 1301.34(a) on or before 

April 27, 2015. Such persons may also 

file a written request for a hearing on 

the application pursuant to 21 CFR 

1301.43 on or before April 27, 2015. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/ODXL, 8701 

Morrissette Drive, Springfield, Virginia 

22152. Request for hearings should be 

sent to: Drug Enforcement 

Administration, Attention: Hearing 

Clerk/LJ, 8701 Morrissette Drive, 

Springfield, Virginia 22152. 

SUPPLEMENTARY INFORMATION: The 

Attorney General has delegated his 

authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, dispensers, 

importers, and exporters of controlled 

substances (other than final orders in 

connection with suspension, denial, or 

revocation of registration) has been 

redelegated to the Deputy Assistant 

Administrator of the DEA Office of 

Diversion Control (‘‘Deputy Assistant 

Administrator’’) pursuant to section 7 of 

28 CFR part 0, appendix of subpart R. 

In accordance with 21 CFR 

1301.34(a), this is notice that on 

December 5, 2014, Meda 

mstockstill on DSK4VPTVN1PROD with NOTICES